MedPath

Radboud University Medical Center

Radboud University Medical Center logo
🇳🇱Netherlands
Ownership
Private
Established
1951-01-01
Employees
-
Market Cap
-
Website
http://www.radboudumc.nl

IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)

Completed
Conditions
Kidney Neoplasms
Clear-cell Metastatic Renal Cell Carcinoma
Interventions
Procedure: Molecular imaging
First Posted Date
2014-08-29
Last Posted Date
2021-12-07
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
40
Registration Number
NCT02228954
Locations
🇳🇱

Radboudumc, Nijmegen, Netherlands

🇳🇱

VU University Medical Center, Amsterdam, Netherlands

🇳🇱

University Medical Center Groningen, Groningen, Netherlands

FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)

Not Applicable
Completed
Conditions
Thyroid Nodule
Thyroid Neoplasms
Interventions
Procedure: Diagnostic Thyroid Surgery
Radiation: FDG-PET/CT
Device: Ultrasound of the head and neck
First Posted Date
2014-08-05
Last Posted Date
2022-05-04
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
132
Registration Number
NCT02208544
Locations
🇳🇱

Radboudumc, Nijmegen, Gelderland, Netherlands

🇳🇱

MUMC, Maastricht, Limburg, Netherlands

🇳🇱

VUmc, Amsterdam, Noord-Holland, Netherlands

and more 12 locations

Effectiveness and Cost-effectiveness of the Energetic Program

Not Applicable
Completed
Conditions
Neuromuscular Diseases
Interventions
Behavioral: Energetic
Other: Control group
First Posted Date
2014-08-05
Last Posted Date
2017-11-07
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
53
Registration Number
NCT02208687
Locations
🇳🇱

Radboudumc, Nijmegen, Gelderland, Netherlands

Implementation of Physical Cancer Rehabilitation Programmes in a European Healthcare System.

Not Applicable
Conditions
Fatigue
Cancer
Interventions
Other: The multi-faceted (MF) strategy
Other: The patient-directed (PD) strategy
First Posted Date
2014-07-31
Last Posted Date
2015-09-07
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
10
Registration Number
NCT02205853
Locations
🇳🇱

Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

MR-guided Focal Laser Ablation of the Prostate

Not Applicable
Completed
Conditions
Prostate Cancer
MRI
Focal Laser Ablation
Interventions
Device: MR-guided focal laser ablation
First Posted Date
2014-07-25
Last Posted Date
2020-04-24
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
20
Registration Number
NCT02200809
Locations
🇳🇱

Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

🇳🇱

Ziekenhuisgroep Twente, Hengelo, Overijssel, Netherlands

🇳🇱

Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands

Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy

Phase 1
Terminated
Conditions
Gastrointestinal Stromal Tumor
Major Gastrectomy
Interventions
Dietary Supplement: cola
First Posted Date
2014-07-10
Last Posted Date
2020-12-08
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
5
Registration Number
NCT02185937
Locations
🇳🇱

Radboudumc, Nijmegen, Netherlands

Role of BCG as Booster Vaccination

Not Applicable
Completed
Conditions
BCG Vaccination
Interventions
Biological: BCG
Biological: TFV
First Posted Date
2014-06-26
Last Posted Date
2016-02-23
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
30
Registration Number
NCT02175420
Locations
🇳🇱

Radboudumc, Nijmegen, Netherlands

Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease

Conditions
COPD
Cancer
Heart Failure
First Posted Date
2014-06-26
Last Posted Date
2014-06-26
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
576
Registration Number
NCT02175147
Locations
🇳🇱

Radboud University Medical Centre Palliative consultation team, Nijmegen, Gelderland, Netherlands

🇧🇪

Katholieke Universiteit Leuven, Leuven, Belgium

🇩🇪

University Hospital Bonn, Bonn, Germany

and more 2 locations

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Phase 2
Completed
Conditions
Acute Myeloid Leucaemia
Myelo Dysplastic Syndrome
Allogeneic Stem Cell Transplant
Acute Graft Versus Host Disease Grade II-IV
Interventions
Other: daily dosing
Other: alternate dosing
Drug: micafungin
First Posted Date
2014-06-24
Last Posted Date
2020-12-08
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
30
Registration Number
NCT02172768
Locations
🇳🇱

Radboudumc, Nijmegen, Netherlands

🇧🇪

UZ Leuven, Leuven, Belgium

Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains

Not Applicable
Completed
Conditions
Malaria
Interventions
Other: NF135 n=1
Other: NF135 n=2
Other: NF166 n=1
Other: NF135 n=5
Other: NF166 n=2
Other: NF166 n=5
First Posted Date
2014-05-29
Last Posted Date
2014-11-24
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
24
Registration Number
NCT02149550
Locations
🇳🇱

UMC St Radboud, Nijmegen, Netherlands

🇳🇱

Havenziekenhuis, Rotterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath